HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways.

AbstractBACKGROUND:
Angelicin is a furocoumarin found in Psoralea corylifolia L. fruit. The purpose of this study was to investigate the protective ability of angelicin against inflammation in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells and LPS-induced in vivo acute lung injury model.
MATERIALS AND METHODS:
The concentrations of tumor necrosis factor alpha (TNF-α) and interleukin (IL)-6 in the culture supernatants of RAW 264.7 cells were determined 24 h after LPS administration. ALI was induced by intratracheal instillation of LPS. Six hours after LPS inhalation, bronchoalveolar lavage fluid and lung tissue samples were obtained for enzyme-linked immunosorbent assay, histologic, and Western blotting analyses.
RESULTS:
The results showed that pretreatment with angelicin markedly downregulated TNF-α and IL-6 levels in vitro and in vivo, and significantly decreased the amount of inflammatory cells, lung wet-to-dry weight ratio, and myeloperoxidase activity in LPS-induced ALI mice. Furthermore, Western blotting analysis results demonstrated that angelicin blocked the phosphorylation of IκBα, NF-κBp65, p38 MAPK, and JNK in LPS-induced ALI.
CONCLUSIONS:
These results suggest that angelicin was potentially advantageous to prevent inflammatory diseases by inhibiting NF-κB and MAPK pathways. Our data indicated that angelicin might be a potential new agent for prevention of inflammatory reactions and diseases in the clinic.
AuthorsFang Liu, Guo-quan Sun, Hua-yi Gao, Rui-sheng Li, Lanan-Wassy Soromou, Na Chen, Yan-hong Deng, Hai-hua Feng
JournalThe Journal of surgical research (J Surg Res) Vol. 185 Issue 1 Pg. 300-9 (Nov 2013) ISSN: 1095-8673 [Electronic] United States
PMID23816246 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents
  • Furocoumarins
  • Interleukin-6
  • Lipopolysaccharides
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • angelicin
Topics
  • Acute Lung Injury (chemically induced, drug therapy, immunology)
  • Animals
  • Anti-Inflammatory Agents (chemistry, pharmacology)
  • Cell Line
  • Cell Survival (drug effects, immunology)
  • Disease Models, Animal
  • Furocoumarins (chemistry, pharmacology)
  • Interleukin-6 (metabolism)
  • Lipopolysaccharides (pharmacology)
  • MAP Kinase Signaling System (drug effects, immunology)
  • Macrophages (cytology, drug effects, immunology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B (immunology, metabolism)
  • Pneumonia (chemically induced, drug therapy, immunology)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: